Baseline Characteristics | |||
Variables | PDS (N = 30)* | IDS (N = 30)* | p-value |
Median age | 49.0 | 55.0 | 0.196 |
BMI (mean, SD) | 24.29 | 23.88 | 0.705 |
Clinical presentation (N, %) |
|
|
|
Mass | 4 (13.3%) | 3 (10.0%) |
|
Distension | 8 (26.7%) | 6 (20.0%) | |
Anorexia and nausea | 1 (3.3%) | 2 (6.7%) | |
Both pain & mass | 5 (16.7%) | 1 (3.3%) | |
Median tumor size (cm) | 12.12 | 10.85 | 0.235 |
CA-125 (U/mL) level (pre NACT vs. post NACT) | - | 1490.77 (±1445.37) vs. 91.59 9 (±219.87) | <0.001 |
CEA (ng/mL) level | 3.6490 (3.11110) | 2.7107 (1.41195) | 0.138 |
ECOG Performance status (N, %) |
|
|
|
PFS 0 | 3 (10%) | 3 (10%) | 0.797 |
PFS 1 | 16 (53.3%) | 13 (43.3%) | |
PFS 2 | 11 (36.7%) | 14 (46.7%) |